$11.32 Billion in Sales Expected for HCA Healthcare Inc (HCA) This Quarter

Brokerages expect HCA Healthcare Inc (NYSE:HCA) to post $11.32 billion in sales for the current fiscal quarter, according to Zacks Investment Research. Nine analysts have made estimates for HCA Healthcare’s earnings, with the lowest sales estimate coming in at $11.19 billion and the highest estimate coming in at $11.61 billion. HCA Healthcare reported sales of $10.62 billion during the same quarter last year, which would suggest a positive year-over-year growth rate of 6.6%. The business is scheduled to announce its next quarterly earnings report on Tuesday, May 1st.

According to Zacks, analysts expect that HCA Healthcare will report full year sales of $11.32 billion for the current year, with estimates ranging from $45.47 billion to $45.99 billion. For the next year, analysts anticipate that the business will post sales of $47.49 billion per share, with estimates ranging from $47.22 billion to $47.74 billion. Zacks’ sales calculations are a mean average based on a survey of sell-side research firms that that provide coverage for HCA Healthcare.

How to Become a New Pot Stock Millionaire

HCA Healthcare (NYSE:HCA) last issued its earnings results on Tuesday, January 30th. The company reported $2.12 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.87 by $0.25. The company had revenue of $11.56 billion for the quarter, compared to analysts’ expectations of $11.19 billion. HCA Healthcare had a net margin of 4.89% and a negative return on equity of 49.49%. The firm’s revenue was up 8.7% compared to the same quarter last year. During the same period in the prior year, the company earned $1.80 earnings per share.

A number of equities analysts have weighed in on the company. Argus upped their price target on HCA Healthcare from $9.26 to $114.00 and gave the stock a “buy” rating in a research report on Monday, February 12th. Zacks Investment Research raised HCA Healthcare from a “hold” rating to a “buy” rating and set a $113.00 target price on the stock in a report on Friday, February 2nd. Sanford C. Bernstein reaffirmed a “market perform” rating and issued a $116.00 price objective (up from $105.00) on shares of HCA Healthcare in a research note on Thursday, February 1st. BMO Capital Markets raised their price objective on HCA Healthcare from $96.00 to $115.00 and gave the company an “outperform” rating in a research note on Thursday, February 1st. They noted that the move was a valuation call. Finally, Morgan Stanley raised their price objective on HCA Healthcare from $84.00 to $91.00 and gave the company an “underweight” rating in a research note on Thursday, February 1st. Three investment analysts have rated the stock with a sell rating, six have issued a hold rating and eighteen have issued a buy rating to the company. HCA Healthcare presently has an average rating of “Buy” and an average price target of $104.50.

Shares of HCA Healthcare (NYSE:HCA) traded up $1.55 on Thursday, hitting $103.90. The company had a trading volume of 1,561,235 shares, compared to its average volume of 1,780,231. The company has a debt-to-equity ratio of -6.58, a current ratio of 1.62 and a quick ratio of 1.36. HCA Healthcare has a 1-year low of $71.18 and a 1-year high of $106.84. The firm has a market cap of $36,355.02, a price-to-earnings ratio of 17.49, a PEG ratio of 1.04 and a beta of 0.49.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, March 30th. Investors of record on Thursday, March 1st will be paid a dividend of $0.35 per share. The ex-dividend date of this dividend is Wednesday, February 28th. This represents a $1.40 dividend on an annualized basis and a dividend yield of 1.35%. HCA Healthcare’s payout ratio is 23.57%.

In related news, insider Charles J. Hall sold 119,637 shares of the business’s stock in a transaction dated Wednesday, February 14th. The stock was sold at an average price of $100.14, for a total transaction of $11,980,449.18. Following the completion of the transaction, the insider now directly owns 161,181 shares in the company, valued at $16,140,665.34. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, major shareholder Thomas F. Frist, Jr. bought 28,650 shares of HCA Healthcare stock in a transaction that occurred on Tuesday, February 20th. The shares were acquired at an average price of $101.07 per share, with a total value of $2,895,655.50. Following the completion of the transaction, the insider now owns 389,855 shares of the company’s stock, valued at $39,402,644.85. The disclosure for this purchase can be found here. Over the last quarter, insiders have sold 482,318 shares of company stock worth $48,394,005. 2.90% of the stock is currently owned by corporate insiders.

A number of hedge funds have recently modified their holdings of HCA. Magellan Asset Management Ltd boosted its holdings in HCA Healthcare by 39.1% during the 4th quarter. Magellan Asset Management Ltd now owns 16,660,349 shares of the company’s stock valued at $1,463,445,000 after acquiring an additional 4,681,672 shares during the period. Lyrical Asset Management LP bought a new position in HCA Healthcare during the 4th quarter valued at approximately $324,051,000. Longview Partners Guernsey LTD raised its position in HCA Healthcare by 8.0% during the 4th quarter. Longview Partners Guernsey LTD now owns 12,022,516 shares of the company’s stock valued at $1,056,058,000 after purchasing an additional 887,361 shares during the last quarter. American Century Companies Inc. raised its position in HCA Healthcare by 49.5% during the 3rd quarter. American Century Companies Inc. now owns 2,558,216 shares of the company’s stock valued at $203,608,000 after purchasing an additional 847,377 shares during the last quarter. Finally, Schroder Investment Management Group raised its position in HCA Healthcare by 167.7% during the 4th quarter. Schroder Investment Management Group now owns 1,213,240 shares of the company’s stock valued at $106,572,000 after purchasing an additional 760,099 shares during the last quarter. Institutional investors own 72.55% of the company’s stock.

COPYRIGHT VIOLATION WARNING: “$11.32 Billion in Sales Expected for HCA Healthcare Inc (HCA) This Quarter” was reported by Markets Daily and is owned by of Markets Daily. If you are reading this piece of content on another site, it was stolen and reposted in violation of United States & international trademark and copyright laws. The original version of this piece of content can be read at https://www.themarketsdaily.com/2018/03/11/11-32-billion-in-sales-expected-for-hca-healthcare-inc-hca-this-quarter.html.

HCA Healthcare Company Profile

HCA Healthcare, Inc, formerly HCA Holdings, Inc, is a holding company. The Company, through its subsidiaries, owns and operates hospitals and related healthcare entities. As of December 31, 2016, the Company operated in two geographically organized groups, including the National and American Groups. As of December 31, 2016, the National Group included 84 hospitals, which were located in Alaska, California, Florida, southern Georgia, Idaho, Indiana, northern Kentucky, Nevada, New Hampshire, South Carolina, Utah and Virginia.

Get a free copy of the Zacks research report on HCA Healthcare (HCA)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply